IntelGenx



Augusta Industries Inc.
Latest Comments
image_pdfimage_print
 

André Godin on the IntelGenx license for Tadalafil erectile dysfunction dosing patent


December 06, 2016
| December 06, 2016

Andre Godin, Executive Vice President and CFO of IntelGenx Technologies Corp. (TSXV: IGX | OTCQX: IGXT), in an interview with […]


IntelGenX changing delivery of famous erectile dysfunction drug


November 22, 2016
| November 22, 2016 | 4 Comments

IntelGenX Technologies Corp. (TSXV: IGX | OTCQX: IGXT) announced the signing of a binding term sheet for a license to […]


IntelGenx reports clinical progress on delivery of Alzheimer’s drug


August 23, 2016
| August 23, 2016 | 1 Comment

IntelGenx Corp. (TSXV: IGX | OTCQX: IGXT) announced that the absorption of montelukast sodium is increased by 52% when delivered […]


 

Aigner: how IntelGenX is forging ahead in fight against dementia


May 11, 2016
| May 11, 2016

IntelGenX Technologies Corp. (TSXV: IGX | OTCQX: IGXT) is a pioneer in innovative drug delivery technologies addressing unmet medical and […]


 

Zerbe: how IntelGenX saw opportunity with oral films


May 10, 2016
| May 10, 2016

IntelGenX Technologies Corp. (TSXV: IGX / OTCQX: IGXT) is a pioneer in innovative drug delivery technologies addressing unmet medical and […]


IntelGenX reports on thin film market rollout, patent


April 21, 2016
| April 21, 2016

IntelGenX Corp. (TSXV: IGX | OTCQX: IGXT) reported progress on the rollout of its oral film drug delivery system, which […]


Prophecy Development Corp.